ArTS Archivio della ricerca di Trieste

SBLATTERO, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.172
EU - Europa 18.977
AS - Asia 16.281
SA - Sud America 5.376
AF - Africa 621
OC - Oceania 398
Continente sconosciuto - Info sul continente non disponibili 33
Totale 70.858
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.140
CN - Cina 5.880
IT - Italia 5.023
BR - Brasile 3.257
SG - Singapore 2.202
DE - Germania 1.691
PL - Polonia 1.679
ES - Italia 1.600
MX - Messico 1.282
GB - Regno Unito 1.238
TR - Turchia 1.174
JP - Giappone 1.171
SE - Svezia 1.126
IN - India 1.082
FR - Francia 1.056
HK - Hong Kong 942
UA - Ucraina 854
ID - Indonesia 767
FI - Finlandia 568
NL - Olanda 544
VN - Vietnam 540
CA - Canada 523
CO - Colombia 491
AR - Argentina 480
PT - Portogallo 474
RU - Federazione Russa 474
KR - Corea 453
TW - Taiwan 445
PE - Perù 389
GR - Grecia 347
CL - Cile 343
AU - Australia 333
AT - Austria 282
CH - Svizzera 261
IE - Irlanda 256
TH - Thailandia 252
BE - Belgio 234
EC - Ecuador 228
RO - Romania 200
BG - Bulgaria 194
SA - Arabia Saudita 182
DK - Danimarca 166
PK - Pakistan 160
EG - Egitto 147
IR - Iran 142
IL - Israele 116
CZ - Repubblica Ceca 106
HU - Ungheria 103
MA - Marocco 103
MY - Malesia 98
ZA - Sudafrica 85
HR - Croazia 81
IQ - Iraq 75
PH - Filippine 75
SI - Slovenia 71
VE - Venezuela 66
RS - Serbia 65
BD - Bangladesh 62
NZ - Nuova Zelanda 62
TN - Tunisia 61
NO - Norvegia 54
LT - Lituania 53
LB - Libano 52
LV - Lettonia 46
PA - Panama 46
AE - Emirati Arabi Uniti 44
JO - Giordania 42
KZ - Kazakistan 41
UY - Uruguay 39
BO - Bolivia 38
CR - Costa Rica 38
PY - Paraguay 37
GT - Guatemala 36
SK - Slovacchia (Repubblica Slovacca) 35
NG - Nigeria 32
DZ - Algeria 31
UZ - Uzbekistan 31
QA - Qatar 27
LK - Sri Lanka 25
HN - Honduras 24
PS - Palestinian Territory 23
NP - Nepal 22
KE - Kenya 21
EU - Europa 20
SY - Repubblica araba siriana 20
BY - Bielorussia 19
DO - Repubblica Dominicana 19
CY - Cipro 18
EE - Estonia 18
ET - Etiopia 18
OM - Oman 18
SN - Senegal 15
GE - Georgia 14
NI - Nicaragua 14
KW - Kuwait 13
AZ - Azerbaigian 12
BA - Bosnia-Erzegovina 12
CU - Cuba 11
MO - Macao, regione amministrativa speciale della Cina 11
PR - Porto Rico 11
Totale 70.601
Salva come PNG Salva come JPEG
Città #
Ashburn 9.483
Woodbridge 1.543
Fairfield 1.441
Houston 1.427
Ann Arbor 1.386
Singapore 1.267
Warsaw 1.150
Germantown 1.013
Chandler 935
Beijing 750
Jacksonville 742
Wilmington 690
Seattle 677
Hong Kong 659
Milan 617
Trieste 574
São Paulo 543
Rome 533
Cambridge 517
Madrid 412
Dallas 397
Hefei 377
Shanghai 368
Munich 351
Guangzhou 347
Tokyo 317
Princeton 315
San Jose 309
Los Angeles 307
Izmir 306
Istanbul 305
Boardman 281
Lima 251
Barcelona 250
Rio de Janeiro 247
Paris 239
Dublin 236
Frankfurt am Main 229
Bogotá 213
New York 211
Hangzhou 205
Seoul 205
Helsinki 204
Ho Chi Minh City 197
Moscow 194
Columbus 186
Buenos Aires 181
Athens 180
Taipei 179
Santiago 176
Sofia 176
Jakarta 172
Lisbon 170
Ankara 166
Chicago 164
The Dalles 164
Vienna 163
Zgierz 152
Hanoi 149
Naples 148
Chengdu 147
Turin 140
Bologna 138
Bangkok 137
Bengaluru 137
London 134
Florence 129
Nanjing 127
Buffalo 119
Curitiba 119
Brasília 112
Chennai 110
Amsterdam 107
Berlin 104
Medellín 104
Mumbai 103
Hyderabad 102
Melbourne 101
Brussels 99
Zurich 99
Jinan 97
Las Vegas 97
Valencia 97
Washington 96
Wuhan 95
San Diego 94
Toronto 94
Quito 93
Sydney 91
Porto 90
Porto Alegre 90
Belo Horizonte 89
Copenhagen 89
Montreal 89
Goiânia 88
Guadalajara 88
Boston 87
Düsseldorf 87
Santa Clara 87
Thessaloniki 87
Totale 39.939
Salva come PNG Salva come JPEG
Nome #
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. 44.619
SINEUPs are modular antisense long non-coding RNAs that increase synthesis of target proteins in cells 395
Targeted delivery of neutralizing anti-C5 antibody to renal endothelium prevents complement- dependent tissue damage 382
Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia 324
Rational design of antirheumatic prodrugs specific for sites of inflammation 311
A non-complement-fixing antibody to  2 glycoprotein I as a novel therapy for antiphospholipid syndrome 310
Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis 307
Anti-transglutaminase antibodies and age. 275
An Albumin-Derived Peptide Scaffold Capable of Binding and Catalysis 270
Selecting soluble/foldable protein domains through single-gene or genomic ORF filtering: structure of the head domain of Burkholderia pseudomallei antigen BPSL2063 268
Anti transglutaminase antibodies cause ataxia in mice. 262
Analyzing the peripheral blood antibody repertoire of a celiac disease patient using phage antibody libraries 258
A reliable screening procedure for coeliac disease in clinical practice. 256
Testing for Anti-Human Transglutaminase Antibodies in Saliva Is Not Useful for Diagnosis of Celiac Disease 250
Looking for celiac disease: diagnostic accuracy of two rapid commercial assays 240
SINEUPs: A new class of natural and synthetic antisense long non-coding RNAs that activate translation 238
A novel quantitative ELISA as accurate and reproducible tool to detect epidermal transglutaminase antibodies in patients with Dermatitis Herpetiformis 237
Using archaeal histones for precise DNA fragmentation , 20: 267-271 (2007) 230
Phage display technology for human monoclonal antibodies 230
One-step cloning of anti tissue transglutaminase scFv from subjects with celiac disease. 229
Diagnostic Delays in Children with Coeliac Disease in the Central European Region 228
Autoantibodies as predictors of disease. 223
Role of anti-osteopontin antibodies in multiple sclerosis and experimental autoimmune encephalomyelitis 221
The Use of Biopsy and "no-Biopsy" Approach for Diagnosing Paediatric Coeliac Disease in the Central European Region 220
Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models 219
Recombinant antibody selections by combining phage and yeast display 216
The gut as site of production of autoimmune antibodies. 215
An Air-well sparging minifermenter system for high-throughput protein production 214
The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments 213
Primer sets for cloning the human repertoire of T cell Receptor variable regions 210
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 209
Dual sugar gut-permeability testing on blood drop in animal models. 208
A Human Monoclonal Antibody Against Domain I Of beta 2-Glycoprotein I prevents Clotting and Fetal Loss Induced By Polyclonal Anti-Phospholipid Antibodies In Animal Models. 206
Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries 205
Molecular dissection of the tissue transglutaminase auto-antibody response in celiac disease 202
Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5 202
Characterization of the anti-tissue transglutaminase antibody response in nonobese diabetic mice. 199
A Functional Idiotype/Anti-Idiotype Network Is Active in Genetically Gluten-Intolerant Individuals Negative for Both Celiac Disease-Related Intestinal Damage and Serum Autoantibodies 197
A definitive set of oligonucleotide primers for amplifying human V regions 195
A label-free immunoassay for Flavivirus detection by the Reflective Phantom Interface technology 194
Interactome-Seq: A Protocol for Domainome Library Construction, Validation and Selection by Phage Display and Next Generation Sequencing 189
N-glycosylation of the mammalian dipeptidyl aminopeptidase-like protein 10 (DPP10) regulates trafficking and interaction with Kv4 channels 189
Antibodies in proteomics II: screening, high-throughput characterization and downstream applications 188
Anti-idiotypic response in mice expressing human autoantibodies. 187
Clinical Presentation in Children With Coeliac Disease in Central Europe 186
Antibodies in proteomics I: generating antibodies 186
A method for rapid and high-yield production of the tick-borne encephalitis virus E and DIII recombinant proteins in E. coli with preservation of the antigenic properties 185
Development of a novel rapid non-invasive screening test for coeliac disease. 183
Antibodies against breain structures in a celiac patient with ataxic syndrome are produced in the intestine 183
Anti-alpha enolase autoantibodies in coeliac disease 183
A deep-blue OLED-based biochip for protein microarray fluorescence detection 183
Anti tTG autoantibodies crossreacting with brain structures are produced in the intestine in celiac patient with equilibrium disorder 181
Impaired glycosylation blocks DPP10 cell surface expression and alters the electrophysiology of i to channel complex 180
Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells 179
Gluten ataxia: passive transfer in a mouse model. 178
Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. 177
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease 175
Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease 174
Antibodies to transglutaminasefrom phage display libraries 174
Differential induction of IL-17, IL-10, and IL-9 in human T helper cells by B7h and B7.1 173
Recombinant renewable polyclonal antibodies 173
Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5. 172
A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects 171
Extending filamentous phage host range by the grafting of a heterologous receptor binding domain 169
A zonulin-occludens toxin synthetic esapeptide modifies the intestinal permeabilità in in-vivo animal model 167
OP0023 Targeted Polymeric Nanoparticles as Diagnostic and Therapeutic Tool for Rheumatoid Arthritis 167
null 166
Profiling the Autoantibody Repertoire by Screening Phage-Displayed Human cDNA Libraries 166
"Recombinant antibodies against human type ii transglutaminase and uses thereof" 164
null 163
Cloning and characyerization of intestinal antibodies to tissue transglutaminase in celiac disease patients 162
Prevalence of celiac disease among risk groups and the general population in USA 161
Protective role of anti-idiotypic network in celiac disease prone subjects 160
Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives. 159
In vivo recombination as a tool to generate molecular diversity in phage antibody libraries 157
The transmembrane β-subunits KCNE1, KCNE2, and DPP6 modify pharmacological effects of the antiarrhythmic agent tedisamil on the transient outward current i to 157
DEVELOPMENT OF CHLORAMBUCIL/HYDROXYCHLOROQUINE-LOADED ANTI-CD20 NANOPARTICLES FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA : IN VITRO MODEL 156
Mass screening for coeliac disease using antihuman transglutaminase antibody assay. 155
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. 155
Management of coeliac disease patients after the confirmation of diagnosis in Central Europe 154
Charecterization of tissue transglutaminase auto-antigenic response using cloned structural domains 153
Plasmid incompatibility: More compatible than previously thought? 153
Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine. 152
Triggering of B7h by the ICOS modulates maturation and migration of monocyte-derived dendritic cells 152
Protective role of anti-idiotypic network in celiac disease prone subjects 150
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca2+ homeostasis 150
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal mucosa anti-transglutaminase antibodies 149
Site of syntesis of antibodies to A-gliadin and tissue-transglutaminase in celiac disease patients 149
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial caco-2 cells 148
Antibody library selection by the {beta}-lactamase protein fragment complementation assay 146
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal-mucosa anti-transglutaminase antibodies 145
Increasing titres of anti-human-transglutaminase antibodies with age in healthy population 144
Selection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity. 144
Engineering mammalian cell factories with SINEUP noncoding RNAs to improve translation of secreted proteins 142
Protective role of anti-idiotypic network in celiac disease prone subjects 141
Human tissue transglutaminase ELISA: powerful massscreening diagnostic assay for coeliac disease 140
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies 140
FRI0030 Anti-TNF-α Antibody Targeted To Inflamed Synovial Tissue for The Treatment of Rheumatoid Arthritis 138
Binders based on dimerised immunoglobulin VH domains 137
Transglutaminase 2-specific coeliac disease autoantibodies induce morphological changes and signs of inflammation in the small-bowel mucosa of mice 137
Totale 63.884
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.903
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.903
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.129 0 0 0 0 0 0 144 218 143 275 104 245
2021/20221.699 86 114 68 138 65 155 74 55 206 177 139 422
2022/20232.648 253 328 213 379 265 483 26 238 285 25 115 38
2023/20241.458 80 78 72 93 154 192 222 271 22 36 132 106
2024/202522.129 40 159 256 319 376 440 241 242 523 417 6.047 13.069
2025/202630.804 5.986 5.063 5.919 5.547 5.332 2.576 381 0 0 0 0 0
Totale 71.367